Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

Cited by (870)

Items 301–400 of 870

1. Leptin, IL-6, and suPAR reflect distinct inflammatory changes associated with adiposity, lipodystrophy and low muscle mass in HIV-infected patients and controls
   Anne Langkilde, Janne Petersen, Jens H. Henriksen, Frank Krieger Jensen, Jan Gerstoft, Jesper Eugen‐Olsen, Ove Andersen · 2015 · Immunity & Ageing
2. Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals
   Felicia C. Chow, W. John Boscardin, Claire Mills, Nerissa Ko, Courtney Carroll, Richard W. Price, Steven G. Deeks, Farzaneh A. Sorond, Priscilla Y. Hsue · 2015 · AIDS
3. Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral Therapy
   Konstantia Angelidou, Peter W. Hunt, ALAN L. LANDAY, Cara C. Wilson, Benigno A. Rodriguez, Steven G. Deeks, Ronald J. Bosch, Michael M. Lederman · 2017 · The Journal of Infectious Diseases
4. Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV
   Patricia A. Cioe, Jason V. Baker, Erna M. Kojic, Nur F. Önen, John Hammer, Pragna Patel, Christopher W. Kahler · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
5. HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet Crosstalk
   Akif A. Khawaja, Kirk A. Taylor, Andrew Lovell, Mark Richard Nelson, Brian Gazzard, Marta Boffito, Michael Emerson · 2020 · Circulation Research
6. Diabetes in HIV: the Link to Weight Gain
   Samuel S. Bailin, John Robert Koethe · 2022 · Current HIV/AIDS Reports
7. Coinfection with Human Herpesvirus 8 Is Associated with Persistent Inflammation and Immune Activation in Virologically Suppressed HIV-Infected Patients
   Mar Masiá, Catalina Robledano, Victoria Ortiz de la Tabla, Pedro Antequera, Blanca Lumbreras, Ildefonso Hernández‐Aguado, Félix Gutiérrez · 2014 · PLoS ONE
8. Impact of CCR5, Integrase and Protease Inhibitors on Human Endothelial Cell Function, Stress, Inflammation and Senescence
   Afonso, Pauline, Auclair, Martine, Caron-Debarle, Martine, Capeau, Jacqueline · 2017 · Antiviral Therapy
9. Insulin Resistance and Markers of Inflammation in HIV-infected Ugandan Children in the CHAPAS-3 Trial
   Sahera Dirajlal‐Fargo, Victor Musiime, Adrian David Cook, Grace Mirembe, Julia M. Kenny, Ying Jiang, Sara M. Debanne, Nigel Jonathan Klein, Grace A. McComsey · 2017 · The Pediatric Infectious Disease Journal
10. HIV-Associated Interactions Between Oral Microbiota and Mucosal Immune Cells: Knowledge Gaps and Future Directions
    Modupe Oluseun Coker, Cristiana Cairo, Alfredo Garzino Demo · 2021 · Frontiers in Immunology
11. The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy
    Ornella Sortino, Kathy Huppler Hullsiek, Elizabeth S. Richards, Adam W. Rupert, Andrea Schminke, Namo Tetekpor, Mariam Quiñones, Rachel A. Prosser, Tim Schacker, Irini Sereti et al. · 2019 · The Journal of Infectious Diseases
12. Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management
    Ilana S. Nazari, Matthew J. Feinstein · 2024 · Clinical Microbiology Reviews
13. Interactions between Human Immunodeficiency Virus Type 1 and Polymorphonuclear Neutrophils
    Sarah Casulli, Carole Elbim · 2013 · Journal of Innate Immunity
14. Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression
    Rodolphe Thiébaut, Charlotte Charpentier, Florence Damond, Audrey Taïeb, Antoine Rachas, Jacqueline Capeau, Geneviève Chêne, Gilles Collin, Sophie Matheron, Diane Descamps et al. · 2012 · Clinical Infectious Diseases
15. Trilobatin as an HIV ‐1 entry inhibitor targeting the HIV ‐1 Gp41 envelope
    Shuwen Yin, Xuanxuan Zhang, Fangyuan Lai, Taizhen Liang, Jiayong Wen, Wanying Lin, Jiayin Qiu, Shuwen Liu, Li Lin · 2018 · FEBS Letters
16. The Effect of a Community-Based Exercise Program on Inflammation, Metabolic Risk, and Fitness Levels Among Persons Living with HIV/AIDS
    Stacy E. Cutrono, John Eugene Lewis, ARLETTE C. PERRY, Joseph F. Signorile, Eduard Tiozzo, Kevin Allen Jacobs · 2015 · AIDS and Behavior
17. Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans
    Joshua Michael Lang, Rebecca Scherzer, Cristin C. Weekley, Phyllis C. Tien, Carl Grünfeld, Michael G. Shlipak · 2013 · AIDS
18. HIV Infection Is Associated With Decreased Thrombin Generation
    Priscilla Y. Hsue, Rebecca Scherzer, Carl Grünfeld, Sarah M. Nordstrom, Amanda Schnell, Louis P. Kohl, Elaine M. Nitta, Jeffrey N. Martin, Steven G. Deeks, Ethan J. Weiss · 2012 · Clinical Infectious Diseases
19. HIV infection, aging and cardiovascular disease: epidemiology and prevention
    Kathy Petoumenos, Signe Westring Worm · 2011 · Sexual Health
20. Association of HIV and Opportunistic Infections With Incident Stroke: A Nationwide Population-Based Cohort Study in Taiwan
    Yung‐Feng Yen, Marcelo Chen, I-An Jen, Yu‐Ching Lan, Pei‐Hung Chuang, Yen-Ling Liu, Yun Jung Lee, Yi‐Ming Arthur Chen · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
21. HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
    Malene Hove‐Skovsgaard, Julie Christine Gaardbo, Lilian Kolte, Kamilla Munch Winding, Ingebjørg Seljeflot, Asbjørn M. Svardal, Rolf Kristian Berge, Jan Gerstoft, Henrik Ullum, Marius Trøseid et al. · 2017 · BMC Infectious Diseases
22. Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data From the Veterans Aging Cohort Study
    Brittanny M. Polanka, Suman Kundu, Kaku So‐Armah, Matthew S. Freiberg, Samir Kumar Gupta, Roger Bedimo, Matthew Jay Budoff, Adeel Ajwad Butt, Chung-Chou H. Chang, Stephen S. Gottlieb et al. · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
23. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
    Ana Gonzalez‐Cordón, Lambert Assoumou, Graeme J Moyle, Laura Jane Waters, Margaret A. Johnson, Peré Domingo, Julie Fox, Hans‐Jürgen Stellbrink, Giovanni Guaraldi, Mar Masiá et al. · 2021 · Journal of Antimicrobial Chemotherapy
24. The Role of Caveolin 1 in HIV Infection and Pathogenesis
    Ayalew Mergia · 2017 · Viruses
25. Neurocognitive functioning predicts frailty index in HIV
    Hannah Oppenheim, Emily W. Paolillo, Raeanne C. Moore, Ronald J. Ellis, Scott Lee Letendre, Dilip V. Jeste, Igor Grant, David J. Moore · 2018 · Neurology
26. Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions
    Torsak Bunupuradah, Trinh Duong, Alexandra Compagnucci, Paddy McMaster, Stefania Bernardi, Suparat Kanjanavanit, Osvalda Rampon, Albert Faye, Yacine Saïdi, Yoann Riault et al. · 2012 · AIDS
27. The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation
    Mark A. Wallet, Caroline M Reist, Julie Williams, Sofia Appelberg, Giorgio Guiulfo, Brent Gardner, John W. Sleasman, Maureen M. Goodenow · 2012 · Journal of Leukocyte Biology
28. Frequency and Risk Factors for Cerebral Arterial Disease in a HIV/AIDS Neuroimaging Cohort
    Nancy J. Edwards, Marie Francisca Grill, H. Alex Choi, Nerissa Ko · 2016 · Cerebrovascular Diseases
29. High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis
    Sihle Ephraim Mabhida, Zandile June‐Rose Mchiza, Kabelo Mokgalaboni, Sidney Hanser, Joel Choshi, Haskly Mokoena, Khanyisani Ziqubu, Charity Mandisa Masilela, Bongani Brian Nkambule, Duduzile Edith Ndwandwe et al. · 2024 · BMC Infectious Diseases
30. Monocyte bioenergetic function is associated with body composition in virologically suppressed HIV-infected women
    Amanda L. Willig, Philip Adam Kramer, Balu K. Chacko, Victor M. Darley-Usmar, Sonya L. Heath, Edgar Turner Overton · 2017 · Redox Biology
31. Human Immunodeficiency Virus Is Associated With Higher Levels of Systemic Inflammation Among Kenyan Adults Despite Viral Suppression
    Sarah J. Masyuko, Stephanie T. Page, Stephen J. Polyak, John Kinuthia, Alfred Onyango Osoti, Fredrick C. F. Otieno, Joseph M. Kibachio, Jerusha N. Mogaka, Paul M Macharia, Bhavna H. Chohan et al. · 2020 · Clinical Infectious Diseases
32. Persistently raised plasma levels of platelet‐derived inflammatory mediators in HIV‐infected patients during highly active anti‐retroviral therapy
    Linn Landrø, Thor Ueland, Kari Otterdal, Stig Sophus Frøland, Pål Aukrust · 2011 · Journal of Thrombosis and Haemostasis
33. The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patients
    Anne Sofie Høgh Kølbæk Kjær, Christel R. Brinkmann, Charles Anthony Dinarello, Rikke Olesen, Lars Jørgen Østergaard, Ole Schmeltz Søgaard, Martin Tolstrup, Thomas A. Rasmussen · 2015 · AIDS
34. Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals
    Rushi V. Parikh, Rebecca Scherzer, Carl Grünfeld, Elaine M. Nitta, Anna Leone, Jeffrey N. Martin, Steven G. Deeks, Peter Ganz, Priscilla Y. Hsue · 2013 · Atherosclerosis
35. Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy
    Eduardo Ticona, Marta E. Bull, Jaime Soria, Kenneth A. Tapia, Jillian Legard, Sheila M. Styrchak, Corey M. Williams, Caroline M. Mitchell, Alberto La Rosa, Robert W. Coombs et al. · 2015 · AIDS
36. Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study
    Julia H. Barton, Alex Ireland, Meghan E. Fitzpatrick, Cathy J. Kessinger, Danielle Camp, Renee Weinman, Deborah K. McMahon, Joseph Ken Leader, Fernando Holguín, Sally E. Wenzel et al. · 2016 · BMC Pulmonary Medicine
37. Immune Dysfunction in HIV: A Possible Role for Pro- and Anti-Inflammatory Cytokines in HIV Staging
    Iorhen E. Akase, Bolanle O. P. Musa, Reginald Obiako, Abdurrahman El-Fulaty Ahmad, Abdullahi Asara Mohammed · 2017 · Journal of Immunology Research
38. Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities
    Talía Sainz, Laura Díaz, María Luisa Navarro, Pablo Rojo, Daniel Blázquez‐Gamero, José Tomás Ramos, María Isabel de José, María Álvarez-Fuente, Sergio Serrano Villar, María José Mellado et al. · 2014 · Atherosclerosis
39. Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance
    Ujjwal Neogi, Anita Shet, Ranjani Shamsundar, Maria L. Ekstrand · 2011 · AIDS
40. Urinary Markers of Tubular Injury in HIV-Infected Patients
    Temesgen Fiseha, Angesom Gebreweld · 2016 · Biochemistry Research International
41. HIV and Global Cardiovascular Health
    Anjali A. Wagle, Erin Goerlich, Wendy S. Post, Bethel Woldu, Kathérine C. Wu, Allison G. Hays · 2022 · Current Cardiology Reports
42. Relationship Between Poor Physical Function, Inflammatory Markers, and Comorbidities in HIV-Infected Women on Antiretroviral Therapy
    Amy S. Baranoski, Ariana Harris, Daniel Michaels, Renee Miciek, Thomas W. Storer, Paola Sebastiani B, Monty A Montano · 2013 · Journal of Women s Health
43. Cardiovascular manifestations of HIV infection in children
    Nikmah Salamia Idris, Diederick E. Grobbee, David Paul Burgner, Michael M.H. Cheung, Nia Kurniati, Sudigdo Sastroasmoro, Cuno S.P.M. Uiterwaal · 2014 · European Journal of Preventive Cardiology
44. Immunovirological parameters and cytokines in HIV infection
    Karen Ingrid Tasca, Sueli Aparecida Calvi, Lenice do Rosário de Souza · 2012 · Revista da Sociedade Brasileira de Medicina Tropical
45. Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study
    José Castillo‐Mancilla, Andrew N. Phillips, James D. Neaton, Jacqueline Neuhaus, Simon Collins, Sharon Mannheimer, Sarah Lilian Pett, Veronique Touzeau‐Römer, Mark Niccolo Polizzotto, Jens Dilling Lundgren et al. · 2017 · Open Forum Infectious Diseases
46. Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated With Increased Inflammatory Markers and Disease Progression
    Damariz Marín-Palma, Gustavo A. Castro, Jaiberth Antonio Cardona‐Arias, Silvio Urcuqui Inchima, Juan Carlos Hernández · 2018 · Frontiers in Immunology
47. HIV and ageing
    Martin Fisher, Vanessa Cooper · 2011 · Current Opinion in Infectious Diseases
48. Comparative DNA methylomic analyses reveal potential origins of novel epigenetic biomarkers of insulin resistance in monocytes from virally suppressed HIV-infected adults
    Christian K. Dye, Michael J. Corley, Dongmei Li, Vedbar S. Khadka, Brooks I. Mitchell, Răzvan Sultana, Annette Lum‐Jones, Cecilia M. Shikuma, Lishomwa C. Ndhlovu, Alika K. Maunakea · 2019 · Clinical Epigenetics
49. Abnormal blood microbiota profiles are associated with inflammation and immune restoration in HIV/AIDS individuals
    Xiaoyan Guo, Zerui Wang, Mengmeng Qu, Yuntian Guo, Minrui Yu, Weiguo Hong, Chao Zhang, Xing Fan, Jin‐Wen Song, Ruonan Xu et al. · 2023 · mSystems
50. Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on Statins
    Martin Kršák, David M. Kent, Norma C. Terrin, Christina Holcroft, Sally C. Skinner, CHRISTINE A. WANKE · 2015 · AIDS Patient Care and STDs
51. Immunosenescence of the CD8+ T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue, metabolism, and muscle in antiretroviral therapy-treated HIV-infected patients and controls
    Juliette Tavenier, Anne Langkilde, Thomas Huneck Haupt, Jens H. Henriksen, Frank Krieger Jensen, Janne Petersen, Ove Andersen · 2015 · BMC Immunology
52. IL-8 Alterations in HIV-1 Infected Children With Disease Progression
    Ambili Nair Pananghat, Heena Aggarwal, Somi Sankaran Prakash, Muzamil Ashraf Makhdoomi, Ravinder Singh, Rakesh Lodha, Shakir Ali, Maddur Srinivas, Bimal Kumar Das, Ravindra Mohan Pandey et al. · 2016 · Medicine
53. Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda
    Crystal M. North, Daniel M. Muyanja, Bernard Kakuhikire, Alexander C. Tsai, Russell P. Tracy, Peter W. Hunt, Douglas S. Kwon, David C. Christiani, Samson Okello, Mark Jacob Siedner · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
54. Association Between HIV Symptom Burden and Inflammatory Cytokines: An Analysis by Sex and Menopause Stage
    Rebecca Schnall, Haomiao Jia, Nancy E. Reame · 2019 · Journal of Women s Health
55. Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling
    Manuel Hayn, Andrea Blötz, Armando Rodríguez, Solange Vidal, Nico Preising, Ludger Ständker, Sebastian Wiese, Christina Martina Stürzel, Mirja Harms, Rüdiger M. Groß et al. · 2021 · Proceedings of the National Academy of Sciences
56. Dual Antiretroviral Therapy—All Quiet Beneath the Surface?
    Berend J. van Welzen, Patrick G. A. Oomen, Andy I. M. Hoepelman · 2021 · Frontiers in Immunology
57. The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels
    Elizabeth Hamlyn, Wolfgang Stöhr, David A. Cooper, Martin Fisher, Giuseppe Tambussi, Mauro Schechter, José María Miró, Fiona M. Vanobberghen, Abdel G. Babiker, Jonathan N Weber et al. · 2015 · AIDS
58. Will expanded ART use reduce the burden of HIV-associated chronic lung disease?
    Ken M. Kunisaki · 2013 · Current Opinion in HIV and AIDS
59. Venous thromboembolism in viral diseases: A comprehensive literature review
    Nasibeh Zerangian, Gisou Erabi, Mohadeseh Poudineh, Kosar Monajjem, Maryam Diyanati, Maryam Khanlari, Amirmohammad Khalaji, Diba Allafi, Arezoo Faridzadeh, Arian Amali et al. · 2023 · Health Science Reports
60. Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study
    Sonja Bjerk, Jason V. Baker, Sean Emery, Jacqueline Neuhaus, Brian Angus, Fred M. Gordin, Sarah Lilian Pett, Christoph Stephan, Ken M. Kunisaki, for the INSIGHT SMART Study Group · 2013 · PLoS ONE
61. Arterial Stiffness Evaluation in HIV-Positive Patients: A Multicenter Matched Control Study
    Giovanna Ferraioli, Carmine Tinelli, Paolo Maggi, Cristina Gervasoni, Pierfrancesco Grima, Klaudija Višković, Scipione Carerj, G. Filice, Carlo Fìlice, the Arterial Stiffness Evaluation in HIV-Infected Subjects Study Group · 2011 · American Journal of Roentgenology
62. HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer
    Barbara S. Taylor, Kaku So‐Armah, Janet P. Tate, Vincent C. Marconi, John Robert Koethe, Roger Bedimo, Adeel Ajwad Butt, Cynthia L. Gibert, Matthew Bidwell Goetz, Maria C. Rodriguez‐Barradas et al. · 2017 · JAIDS Journal of Acquired Immune Deficiency Syndromes
63. Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals
    Javier Juega, Anna Bonjoch, Núria Pérez‐Álvarez, Eugènia Negredo, Beatriu Bayés, Josep Bonet, Buenaventura Clotet, Ramón Romero · 2017 · Medicine
64. The impact of integrase inhibitor-based regimens on markers of inflammation among HIV naïve patients
    Eugenia Quirós-Roldán, Francesco Castelli, Andrea Bonito, Marika Vezzoli, Stefano Calza, Giorgio Biasiotto, Isabella Zanella · 2019 · Cytokine
65. Venous thromboembolism in people living with HIV infection (PWH)
    Chiara Agrati, Valentina Mazzotta, Carmela Pinnetti, Gianluigi Biava, Michele Bibas · 2020 · Translational research
66. Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid Tissues
    Meghan K. Rothenberger, Krystelle Nganou‐Makamdop, Cissy M Kityo, Francis Ntengereze Ssali, Jeffrey G. Chipman, Gregory J. Beilman, Torfi Hoskuldsson, Jodi L. Anderson, Jake S. Jasurda, Thomas E. Schmidt et al. · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
67. Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial
    Stephen John Kent, Sally Hough, Anthony Dominic Kelleher, Matthew G. Law, Jolie L. Hutchinson, Marta Catálfamo, David J van Bockel, Cliff Lane, Jason V. Baker, Sean Emery · 2018 · The Lancet HIV
68. Losartan to reduce inflammation and fibrosis endpoints in HIV disease
    Jason V. Baker, Julian A. Wolfson, Gary Collins, Caryn Gee Morse, Frank S. Rhame, Angelike P. Liappis, Stacey A. Rizza, Zelalem Temesgen, Harry A Mystakelis, Steven G. Deeks et al. · 2020 · AIDS
69. A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1–Infected Patients: 48-Week Results of the SHIELD Trial
    Benjamin Young, Thanes Vanig, Edwin DeJesus, Trevor Hawkins, Marty St. Clair, Linda Yau, Belinda Ha, SHIELD Study Team · 2010 · HIV Clinical Trials
70. T Lymphocyte Subsets Associated With Prevalent Diabetes in Veterans With and Without Human Immunodeficiency Virus
    Samuel S. Bailin, Kathleen A. McGinnis, Wyatt J. McDonnell, Kaku So‐Armah, Melissa Wellons, Russell P. Tracy, Margaret F. Doyle, Simon Alexander Mallal, Amy C. Justice, Matthew S. Freiberg et al. · 2020 · The Journal of Infectious Diseases
71. The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging
    Stephanie Shiau, Alexis Anne Bender, Jane A. O’Halloran, Erin E. Sundermann, Juhi Aggarwal, Keri N. Althoff, Jason V. Baker, Steven G. Deeks, Linda P. Fried, Stephen E. Karpiak et al. · 2020 · AIDS Research and Human Retroviruses
72. Serum interleukin-6 levels are increased in HIV-infected patients that develop autoimmune disease during long-term follow-up
    Maria Concetta Trovato, Rosaria Maddalena Ruggeri, Salvatore Sciacchitano, Teresa Manuela Vicchio, Isa Picerno, Giovanni Francesco Pellicanò, Andrea Valenti, Giuseppa Visalli · 2017 · Immunobiology
73. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
    Yexin Yang, Akiko Iwasaki · 2021 · Current HIV/AIDS Reports
74. Circulating CD4+ TEMRA and CD4+ CD28− T cells and incident diabetes among persons with and without HIV
    Samuel S. Bailin, Suman Kundu, Melissa Wellons, Matthew S. Freiberg, Margaret F. Doyle, Russell P. Tracy, Amy C. Justice, Celestine N. Wanjalla, ALAN L. LANDAY, Kaku So‐Armah et al. · 2021 · AIDS
75. Targeted Application of Functional Foods as Immune Fitness Boosters in the Defense against Viral Infection
    Dearbhla Finnegan, Restituto Tocmo, Christine E. Loscher · 2023 · Nutrients
76. Role of biomarkers in predicting CVD risk in the setting of HIV infection?
    Signe Westring Worm, Priscilla Y. Hsue · 2010 · Current Opinion in HIV and AIDS
77. Rate and Predictors of Carotid Artery Intima Media Thickness Progression in Antiretroviral-Naive HIV-Infected and Uninfected Adults: A 48-Week Matched Prospective Cohort Study
    Corrilynn O. Hileman, Teresa L. Carman, Chris Todd Longenecker, Danielle E. Labbato, Norma J. Storer, Cynthia A. White, Grace A. McComsey · 2013 · Antiviral Therapy
78. Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects
    Didier Scherrer, Regine Rouzier, P. Noel Barrett, Jean-Marc Steens, Paul Gineste, Robert L. Murphy, Jamal Tazi, Hartmut J. Ehrlich · 2016 · Journal of Antimicrobial Chemotherapy
79. Silymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cells
    Erica S. Lovelace, Nicholas Joseph Maurice, Hannah W. Miller, Chloe K. Slichter, Robert D. Harrington, Amalia Magaret, Martin Prlic, Stephen C. De Rosa, Stephen J. Polyak · 2017 · PLoS ONE
80. Similarity in viral and host promoters couples viral reactivation with host cell migration
    Kathrin Bohn-Wippert, Erin N. Tevonian, Melina R. Megaridis, Roy D. Dar · 2017 · Nature Communications
81. Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls
    L. Van den Dries, Mark A. A. Claassen, Zwier M. A. Groothuismink, Eric C. M. Van Gorp, André Boonstra · 2017 · Virology
82. Deciphering Endothelial Dysfunction in the HIV-Infected Population
    Genevieve Mezoh, Nigel John Crowther · 2019 · Advances in experimental medicine and biology
83. Pilot study of vascular health in survivors of Hodgkin lymphoma
    Daniel A. Mulrooney, Kirsten K. Ness, Anna N. Solovey, Robert P. Hebbel, James D. Neaton, Bruce A. Peterson, Chung K.K. Lee, Aaron S. Kelly, Joseph Philip Neglia · 2012 · Pediatric Blood & Cancer
84. Macropinocytosis and TAK1 mediate anti-inflammatory to pro-inflammatory macrophage differentiation by HIV-1 Nef
    Michihiro Hashimoto, Hesham Nasser, Takashi Chihara, Shinya Suzu · 2014 · Cell Death and Disease
85. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy
    Grace C. Haser, Bauer E. Sumpio · 2016 · Journal of Vascular Surgery
86. Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel
    Craig James Beavers, Alice K. Pau, David V. Glidden, Emily Parker Hyle, Safia Kuriakose, Seth Shay Martin, Grace A. McComsey, Melanie Thompson, Salim S. Virani, Jason V. Baker · 2025 · Annals of Internal Medicine
87. Disease-Modifying Therapeutic Concepts for HIV in the Era of Highly Active Antiretroviral Therapy
    Scott L. Butler, Hernán Valdez, Michael Westby, Manos Perros, Carl H. June, Jeffrey M. Jacobson, Yves Lévy, David A. Cooper, Daniel C. Douek, Michael M. Lederman et al. · 2011 · JAIDS Journal of Acquired Immune Deficiency Syndromes
88. Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
    Sergio Serrano Villar, María Rosa López‐Huertas, Daniel Jiménez, Carlos Galera, Javier Martínez‐Sanz, Elena Moreno, Alfonso Muriel, Félix Gutiérrez, Carmen Busca, Joaquín Portilla et al. · 2022 · Frontiers in Immunology
89. The pathogenesis of obesity in people living with HIV
    Samuel S. Bailin, John Robert Koethe, Peter F. Rebeiro · 2023 · Current Opinion in HIV and AIDS
90. Association of Inflammatory Cytokines and Endothelial Adhesion Molecules with Immunological, Virological, and Cardiometabolic Disease in HIV-Infected Individuals
    Heloísa Ramos Lacerda, Maria da Conceição Correia Falcão, Valéria Maria Gonçalves de Albuquerque, Josefina Cláudia Zírpoli, Demócrito de Barros Miranda-Filho, Maria de Fátima Pessoa Militão de Albuquerque, Ulísses Ramos Montarroyos, Ricardo Arraes de Alencar Ximenes · 2013 · Journal of Interferon & Cytokine Research
91. Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study
    Kaku So‐Armah, Emily Kate Quinn, Debbie M. Cheng, Russell P. Tracy, Jason V. Baker, Jeffrey H. Samet, Matthew S. Freiberg · 2013 · BMC Infectious Diseases
92. Inflammation in HIV-Infected Patients: Impact of HIV, Lifestyle, Body Composition, and Demography – A Cross Sectional Cohort Study
    Anne Langkilde, Janne Petersen, Henrik Hedegaard Klausen, Jens H. Henriksen, Jesper Eugen‐Olsen, Ove Andersen · 2012 · PLoS ONE
93. Atherosclerosis is Evident in Treated HIV-Infected Subjects With Low Cardiovascular Risk by Carotid Cardiovascular Magnetic Resonance
    Kathleen A. M. Rose, Jaime H. Vera, Peter Drivas, WINSTON A. S. BANYA, Niall Keenan, Dudley John Pennell, Alan Winston · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
94. Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy
    Simone Belmonti, Francesca Lombardi, Eugenia Quirós-Roldán, Alessandra Latini, Antonella Castagna, Alberto Borghetti, Gianmaria Baldin, Arturo Ciccullo, Roberto Cauda, Andrea De Luca et al. · 2018 · Journal of Antimicrobial Chemotherapy
95. How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?
    Htein Linn Aung, Scherazad Kootar, Thomas M. Gates, Bruce James Brew, Lucette A. Cysique · 2019 · European Geriatric Medicine
96. Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression
    Nicholas Musinguzi, José Castillo‐Mancilla, Mary Morrow, Helen Byakwaga, Samantha MaWhinney, Tricia H. Burdo, Yap Boum, Conrad K. Muzoora, Bosco M. Bwana, Mark Jacob Siedner et al. · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
97. Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort
    Ashwin Balagopal, Nikhil Gupte, Rupak Shivakoti, Andrea L. Cox, Wei-Teng Yang, Sima Berendes, Noluthando Mwelase, Cecilia Kanyama, Sandy Pillay, Wadzanai P. Samaneka et al. · 2016 · Open Forum Infectious Diseases
98. Purinergic Receptors: Elucidating the Role of these Immune Mediators in HIV-1 Fusion
    Tracey L. Freeman, Talia H. Swartz · 2020 · Viruses
99. The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome
    П. П. Авдонин, Maria S. Blinova, Галина Анатольевна Генералова, Khadizha Emirova, Pavel V. Avdonin · 2023 · Biomolecules
100. Hot Immunological Topics in HIV Infection
     Juan Antonio Pineda, José Alcamı́, José Ramón Blanco, Julià Blanco, Vicente Boix · 2011 · Journal of AIDS & Clinical Research